Share Market Highlights 24 November 2023: Indices trade flat, Nifty settles below 19,800
Lupin: The pharma major has received approval from the U.S. FDA for Bromfenac Ophthalmic Solution, 0.07%, and tentative approval from
Continue readingThe Number One Finance & Business Blog!
Lupin: The pharma major has received approval from the U.S. FDA for Bromfenac Ophthalmic Solution, 0.07%, and tentative approval from
Continue reading